articleThe LancetDec 1, 2002Closed access

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

HHHans‐Peter HartungRGR GonsetteNKNikolaus KönigHKHubert KwiecińskiAGA. Guseo

Heinrich Heine University Düsseldorf · Bayer (Germany) · +5 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

944
total citations
FWCI
26.08
Percentile
100%
References
34
Citations per year

Authors

8

Topics & keywords

Topics
Keywords
  • Mitoxantrone
  • Medicine
  • Placebo
  • Internal medicine
  • Adverse effect
  • Clinical endpoint
  • Multiple sclerosis
  • Clinical trial
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding